Advances in Drug Design and Discovery is a peer-reviewed journal that focuses on publishing original research, short communications, reviews/mini-reviews and guest-edited thematic issues related to the identification, design, and development of drugs. The journal also encourages the exploration of emerging technologies, such as artificial intelligence, CRISPR-based target validation, structure-based drug design and novel computational and experimental approaches that enhance drug efficacy, selectivity, and safety.

The journal covers a broad spectrum of topics in drug design, discovery, and development, including but not limited to:

• Artificial intelligence in drug design
• Computational chemistry and molecular modeling
• Docking and molecular dynamics
• Drug design and discovery
• Drug discovery for neglected diseases
• Fragment-based drug discovery
• High-throughput screening
• Hit to lead optimization
• Lead compound optimization
• Ligand-based drug design
• Medicinal chemistry
• Multi-target drug design
• Natural products in drug discovery
• Nucleic acid-based drugs
• Peptide and protein therapeutics
• Pharmacophore modeling
• Structure–activity relationship (SAR/QSAR)
• Structure-based drug design
• Target identification and validation
• Virtual screening

Advances in Drug Design and Discovery is an international, peer-reviewed journal on all aspects of drug design and discovery, published continuously (print & online) by Bentham Science Publishers.